AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/134
ERCC1 MESSENGER-RNA LEVELS COMPLEMENT THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN PREDICTING RESPONSE AND SURVIVAL FOR GASTRIC-CANCER PATIENTS RECEIVING COMBINATION CISPLATIN AND FLUOROURACIL CHEMOTHERAPY
Authors: METZGER R LEICHMAN CG DANENBERG KD DANENBERG PV LENZ HJ HAYASHI K GROSHEN S SALONGA D COHEN H LAINE L CROOKES P SILBERMAN H BARANDA J KONDA K LEICHMAN L
Citation: R. Metzger et al., ERCC1 MESSENGER-RNA LEVELS COMPLEMENT THYMIDYLATE SYNTHASE MESSENGER-RNA LEVELS IN PREDICTING RESPONSE AND SURVIVAL FOR GASTRIC-CANCER PATIENTS RECEIVING COMBINATION CISPLATIN AND FLUOROURACIL CHEMOTHERAPY, Journal of clinical oncology, 16(1), 1998, pp. 309-316
LOW-RATE OF EMERGENCE OF CLARITHROMYCIN-RESISTANT HELICOBACTER-PYLORIWITH AMOXICILLIN CO-THERAPY
Authors: LAINE L SUCHOWER L FRANTZ J CONNORS A NEIL G
Citation: L. Laine et al., LOW-RATE OF EMERGENCE OF CLARITHROMYCIN-RESISTANT HELICOBACTER-PYLORIWITH AMOXICILLIN CO-THERAPY, Alimentary pharmacology & therapeutics, 12(9), 1998, pp. 887-892
US DOUBLE-BLIND, CONTROLLED TRIALS OF OMEPRAZOLE AND AMOXICILLIN FOR TREATMENT OF HELICOBACTER-PYLORI
Authors: LAINE L JOHNSON E SUCHOWER L RONCA P HWANG C NEIL G
Citation: L. Laine et al., US DOUBLE-BLIND, CONTROLLED TRIALS OF OMEPRAZOLE AND AMOXICILLIN FOR TREATMENT OF HELICOBACTER-PYLORI, Alimentary pharmacology & therapeutics, 12(4), 1998, pp. 377-382
HELICOBACTER-PYLORI AND PEPTIC-ULCER DISEASE - BRIDGING THE GAP BETWEEN KNOWLEDGE AND TREATMENT
Authors: LAINE L FENDRICK AM
Citation: L. Laine et Am. Fendrick, HELICOBACTER-PYLORI AND PEPTIC-ULCER DISEASE - BRIDGING THE GAP BETWEEN KNOWLEDGE AND TREATMENT, Postgraduate medicine, 103(3), 1998, pp. 231
ACCURACY OF CLOTEST AFTER HELICOBACTER-PYLORI THERAPY
Authors: LAINE L SUCHOWER L JOHNSON E RONCA P NEIL G
Citation: L. Laine et al., ACCURACY OF CLOTEST AFTER HELICOBACTER-PYLORI THERAPY, Gastrointestinal endoscopy, 47(3), 1998, pp. 250-253
EFFECT OF BLOOD ON RAPID UREASE TESTING OF GASTRIC-MUCOSAL BIOPSY SPECIMENS
Authors: LAINE L SIDHOM O EMAMI S ESTRADA R COHEN H
Citation: L. Laine et al., EFFECT OF BLOOD ON RAPID UREASE TESTING OF GASTRIC-MUCOSAL BIOPSY SPECIMENS, Gastrointestinal endoscopy, 47(2), 1998, pp. 141-143
AN EVIDENCE-BASED APPROACH TO GASTROENTEROLOGY THERAPY
Authors: SCHOENFELD P COOK D HAMILTON F LAINE L MORGAN D PETERSON W
Citation: P. Schoenfeld et al., AN EVIDENCE-BASED APPROACH TO GASTROENTEROLOGY THERAPY, Gastroenterology, 114(6), 1998, pp. 1318-1325
VALIDATION OF THE C-13-UREA BLOOD-TEST FOR HELICOBACTER-PYLORI INFECTION - A US, MULTICENTER TRIAL
Authors: CHEY WD MURTHY U TOSKES P CARPENTER S LAINE L
Citation: Wd. Chey et al., VALIDATION OF THE C-13-UREA BLOOD-TEST FOR HELICOBACTER-PYLORI INFECTION - A US, MULTICENTER TRIAL, Gastroenterology, 114(4), 1998, pp. 371-371
ONCE-DAILY THERAPY FOR HELICOBACTER-PYLORI - A RANDOMIZED COMPARISON OF 4 REGIMENS
Authors: LAINE L ESTRADA R TRUJILLO M CHEYBANI K",YERAMIAN,"SMITH S NEIL G
Citation: L. Laine et al., ONCE-DAILY THERAPY FOR HELICOBACTER-PYLORI - A RANDOMIZED COMPARISON OF 4 REGIMENS, Gastroenterology, 114(4), 1998, pp. 791-791
PROSPECTIVE EVALUATION OF THE EFFECT OF PROTON PUMP INHIBITOR THERAPYON HELICOBACTER-PYLORI DIAGNOSTIC TESTING
Authors: LAINE L ESTRADA R TRUJILLO M KNIGGE C FENNERTY MB
Citation: L. Laine et al., PROSPECTIVE EVALUATION OF THE EFFECT OF PROTON PUMP INHIBITOR THERAPYON HELICOBACTER-PYLORI DIAGNOSTIC TESTING, Gastroenterology, 114(4), 1998, pp. 792-792
REDUCED RISK OF CLARITHROMYCIN-RESISTANT HELICOBACTER-PYLORI WITH AMOXICILLIN COTHERAPY - RESULTS FROM 3 MULTICENTER DOUBLE-BLIND US TRIALS
Authors: LAINE L SUCHOWER L CONNORS A FRANTZ J NEIL G
Citation: L. Laine et al., REDUCED RISK OF CLARITHROMYCIN-RESISTANT HELICOBACTER-PYLORI WITH AMOXICILLIN COTHERAPY - RESULTS FROM 3 MULTICENTER DOUBLE-BLIND US TRIALS, Gastroenterology, 114(4), 1998, pp. 793-793
TWICE-DAILY 10-DAY TRIPLE THERAPY WITH OMEPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN FOR HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - RESULTS OF 3 MULTICENTER, DOUBLE-BLIND, US TRIAL
Authors: LAINE L SUCHOWER L CONNORS A FRANTZ J NEIL G
Citation: L. Laine et al., TWICE-DAILY 10-DAY TRIPLE THERAPY WITH OMEPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN FOR HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - RESULTS OF 3 MULTICENTER, DOUBLE-BLIND, US TRIAL, Gastroenterology, 114(4), 1998, pp. 794-794
1-WEEK VS. 2-WEEK BISMUTH SUBSALICYLATE-BASED TRIPLE THERAPY FOR HELICOBACTER-PYLORI - RESULTS OF A US RANDOMIZED TRIAL
Authors: YANG R HAMAMOTO R LAINE L
Citation: R. Yang et al., 1-WEEK VS. 2-WEEK BISMUTH SUBSALICYLATE-BASED TRIPLE THERAPY FOR HELICOBACTER-PYLORI - RESULTS OF A US RANDOMIZED TRIAL, Gastroenterology, 114(4), 1998, pp. 1388-1388
IA-2 ANTIBODIES - A SENSITIVE MARKER OF IDDM WITH CLINICAL ONSET IN CHILDHOOD AND ADOLESCENCE
Authors: SAVOLA K BONIFACIO E SABBAH E KULMALA P VAHASALO P KARJALAINEN J TUOMILEHTOWOLF E MERILAINEN J AKERBLOM HK KNIP M AKERBLOM HK TUOMILEHTO J LOUNAMAA R TOIVONEN L VIRTALA E PITKANIEMI J FAGERLUND A FLITTNER M GUSTAFSSON B HAGGQUIST M HAKULINEN A HERVA L HILTUNEN P HUHTAMAKI T HUTTUNEN NP HUUPPONEN T JOKI T JOKISALO R KAAR ML KALLIO S KAPRIO EA KASHI U KNIP M LAINE L LAPPALAINEN J MAENPAA J MAKELA AL NIEMI K NIIRANEN A NUUJA A OJAJARVI P OTONKOSKI T PIHLAJAMAKI K PONTYNEN S RAJANTIE J SANKALA J SCHUMACHER J SILLANPAA M STAHLBERG MR STRAHLMANN CH UOTILA T VARE M VARIMO P WETTERSTRAND G ARO A HILTUNEN M HURME H HYOTY H ILONEN J KARJALAINEN J KNIP M LEINIKKI P MIETTINEN A PETAYS T RASANEN L REIJONEN H REUNANEN A SAUKKONEN T SAVILAHTI E TUOMILEHTOWOLF E VAHASALO P VIRTANEN SM
Citation: K. Savola et al., IA-2 ANTIBODIES - A SENSITIVE MARKER OF IDDM WITH CLINICAL ONSET IN CHILDHOOD AND ADOLESCENCE, Diabetologia, 41(4), 1998, pp. 424-429
EFFECT OF PROTON-PUMP INHIBITOR THERAPY ON DIAGNOSTIC TESTING FOR HELICOBACTER-PYLORI
Authors: LAINE L ESTRADA R TRUJILLO M KNIGGE K FENNERTY MB
Citation: L. Laine et al., EFFECT OF PROTON-PUMP INHIBITOR THERAPY ON DIAGNOSTIC TESTING FOR HELICOBACTER-PYLORI, Annals of internal medicine, 129(7), 1998, pp. 547-550
HAS THE IMPACT OF HELICOBACTER-PYLORI THERAPY ON ULCER RECURRENCE IN THE UNITED-STATES BEEN OVERSTATED - A METAANALYSIS OF RIGOROUSLY DESIGNED TRIALS
Authors: LAINE L HOPKINS RJ GIRARDI LS
Citation: L. Laine et al., HAS THE IMPACT OF HELICOBACTER-PYLORI THERAPY ON ULCER RECURRENCE IN THE UNITED-STATES BEEN OVERSTATED - A METAANALYSIS OF RIGOROUSLY DESIGNED TRIALS, The American journal of gastroenterology, 93(9), 1998, pp. 1409-1415
TWICE-DAILY, 10-DAY TRIPLE THERAPY WITH OMEPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN FOR HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - RESULTS OF 3 MULTICENTER, DOUBLE-BLIND, UNITED-STATES TRIALS
Authors: LAINE L SUCHOWER L FRANTZ J CONNERS A NEIL C
Citation: L. Laine et al., TWICE-DAILY, 10-DAY TRIPLE THERAPY WITH OMEPRAZOLE, AMOXICILLIN, AND CLARITHROMYCIN FOR HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - RESULTS OF 3 MULTICENTER, DOUBLE-BLIND, UNITED-STATES TRIALS, The American journal of gastroenterology, 93(11), 1998, pp. 2106-2112
EVALUATION OF THE FLEXSURE HP WHOLE-BLOOD ANTIBODY-TEST FOR DIAGNOSISOF HELICOBACTER-PYLORI INFECTION
Authors: SADOWSKI D COHEN H LAINE L GREENBERG P GOLDSTEIN J MIHALOV M CUTLER AF
Citation: D. Sadowski et al., EVALUATION OF THE FLEXSURE HP WHOLE-BLOOD ANTIBODY-TEST FOR DIAGNOSISOF HELICOBACTER-PYLORI INFECTION, The American journal of gastroenterology, 93(11), 1998, pp. 2119-2123
HLA-DR4 SUBTYPE AND -B ALLELES IN DQB1-ASTERISK-0302-POSITIVE HAPLOTYPES ASSOCIATED WITH IDDM
Authors: REIJONEN H NEJENTSEV S TUOKKO J KOSKINEN S TUOMILEHTOWOLF E AKERBLOM HK ILONEN J LOUNAMAA R TOIVANEN L KAPRIO EA VIRTALA E PITKANIEMI J FAGERLUND A FLITTNER M GUSTAFSSON B HAGGQVIST C HAKULINEN A HERVA L HILTUNEN P HUHTAMAKI T HUTTUNEN NP HUUPPONEN T HYTTINEN M JOKI T JOKISALO R KAAR ML KALLIO S KASKI U KNIP M LAINE L LAPPALAINEN J MAENPAA J MAKELA AL NIEMI K NIIRANEN A NUUJA A OJAJARVI P OTONKOSKI T PIHLAJAMAKI K PONTYNEN S RAJANTIE J SANKALA J SCHUMACHER J SILLANPAA M STALBERG MR STRAHLMANN C UOTILA T VARE M VARIMO P WETTERSTRAND G ARO A HILTUNEN M HURME H HYOTY H KARJALAINEN J LEINIKKI P MIETTINEN A PETAYS T RASANEN L REUNANEN A SAUKKONEN T SAVILAHTI E VAHASALO P VIRTANEN SM
Citation: H. Reijonen et al., HLA-DR4 SUBTYPE AND -B ALLELES IN DQB1-ASTERISK-0302-POSITIVE HAPLOTYPES ASSOCIATED WITH IDDM, European journal of immunogenetics, 24(5), 1997, pp. 357-363
POOR BETA-CELL FUNCTION AFTER THE CLINICAL MANIFESTATIONS OF TYPE-1 DIABETES IN CHILDREN INITIALLY POSITIVE FOR ISLET-CELL SPECIFIC AUTOANTIBODIES
Authors: KOMULAINEN J KNIP M LOUNAMAA R VAHASALO P KARJALAINEN J SABBAH E AKERBLOM HK TUOMILEHTO J TOIVANEN L VIRTALA E PITKANIEMI J FAGERLUND A FLITTNER M GUSTAFSSON B HAGGQUIST C HAKULINEN A HERVA L HILTUNEN P HUHTAMAKI T HUTTUNEN NP HUUPPONEN T HYTTINEN M JOKI T JOKISALO R KAAR ML KALLIO S KAPRIO EA KASKI U LAINE L LAPPALAINEN J MAENPAA J MAKELA AL NIEMI K NIIRANEN A NUUJA A OJAJARVI P OTONKOSKI T PIHLAJAMAKI K PONTYNEN S RAJANTIE J SANKALA J SCHUMACHER J SILLANPAA M STAHLBERG MR STRAHLMANN CH UOTILA T VARE M VARIMO P WETTERWSTRAND G ARO A HILTUNEN M HURME H HYOTY H ILONEN J LIENIKKI P MIETTINEN A PETAYS T RASANEN L REIJONEN H REUNANEN A SAUKKONEN T SAVILAHTI E TUOMILEHTOWOLF E VIRTANEN SM
Citation: J. Komulainen et al., POOR BETA-CELL FUNCTION AFTER THE CLINICAL MANIFESTATIONS OF TYPE-1 DIABETES IN CHILDREN INITIALLY POSITIVE FOR ISLET-CELL SPECIFIC AUTOANTIBODIES, Diabetic medicine, 14(7), 1997, pp. 532-537
A UNITED-STATES MULTICENTER TRIAL OF DUAL AND PROTON PUMP INHIBITOR-BASED TRIPLE THERAPIES FOR HELICOBACTER-PYLORI
Authors: LAINE L FRANTZ JE BAKER A NEIL GA
Citation: L. Laine et al., A UNITED-STATES MULTICENTER TRIAL OF DUAL AND PROTON PUMP INHIBITOR-BASED TRIPLE THERAPIES FOR HELICOBACTER-PYLORI, Alimentary pharmacology & therapeutics, 11(5), 1997, pp. 913-917
MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - PROCEEDINGS FROM A 3RD ROUND-TABLE MEETING HELD IN ASCOT, JUNE 1996 - INTRODUCTION
Authors: LAINE L
Citation: L. Laine, MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - PROCEEDINGS FROM A 3RD ROUND-TABLE MEETING HELD IN ASCOT, JUNE 1996 - INTRODUCTION, Alimentary pharmacology & therapeutics, 11, 1997, pp. 1-1
ENDOSCOPIC METHODS FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI
Authors: COHEN H LAINE L
Citation: H. Cohen et L. Laine, ENDOSCOPIC METHODS FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI, Alimentary pharmacology & therapeutics, 11, 1997, pp. 3-9
EVALUATION OF TAP1 POLYMORPHISMS WITH INSULIN-DEPENDENT DIABETES-MELLITUS IN FINNISH DIABETIC-PATIENTS
Authors: MA LD PENFORNIS A WANG XL SCHOENFELD D AKERBLOM HK TUOMILEHTO J LOUNAMAA R TOIVANEN L FAGERLUND A FLITTNER M GUSTAFSSON B HAGGQVIST C HAKULINEN A HERVA L HILTUNEN P HUHTAMAKI T HUTTUNAN NP HUUPPONEN T HYTTINEN M JOKI T JOKISALO R KAAR ML KALLIO S KAPRIO EA KASKI U KNIP M LAINE L LAPPALAINEN J MAENPAA J MAKELA AL NIEMI K NIIRANEN A NUUJA A OJAJARVI P OTONKOSKI T PIHLAJAMAKI K PONTYNEN S RAJANTIE J SANKALA J SCHUMACHER J SILLANPAA M STAHLBERG MR STRAHLMANN CH UOTILA T VARE M VARIMO P WETTENSTRAND G TUOMILEHTOWOLF E METCALFE K HITMAN G FAUSTMAN D
Citation: Ld. Ma et al., EVALUATION OF TAP1 POLYMORPHISMS WITH INSULIN-DEPENDENT DIABETES-MELLITUS IN FINNISH DIABETIC-PATIENTS, Human immunology, 53(2), 1997, pp. 159-166
CHOLESTEROL-LOWERING AFTER PARTICIPATION IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) IN FINLAND
Authors: STRANDBERG TE LEHTO S PYORALA K KESANIEMI A OKSA H MIETTINEN TA VANHANEN H HOLTTA K LUOMANMAKI H PEKURI T VUORINEN A PASTERNACK A SIITONEN L RIMPI R LILJA M KORHONEN T RANTALA A RANTALA M SAVOLAINEN M UKKOLA O LAINE L VIRKKALA L RANTALA A MIETTINEN H AARTOLAHTI A RAISANEN R
Citation: Te. Strandberg et al., CHOLESTEROL-LOWERING AFTER PARTICIPATION IN THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) IN FINLAND, European heart journal, 18(11), 1997, pp. 1725-1727
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>